AAD 2026Abstract 73554
Roflumilast Cream 0.3% and Foam 0.3% Provide Improvement Across Psoriasis Area and Severity Index Body Regions and Clinical Signs for Patients With Plaque Psoriasis
Gooderham MJ, Bhutani T, Young M, Armstrong A, Lebwohl MG, Bukhalo M, Ferris LK, Weiss SC, Krupa D, Seal MS, Hanna D
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisJAK inhibitors & other targeted pillsTopical treatments
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1568 · Not in PubMed: details from Crossref